Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Liaoning Xinshanyuan Pharmaceutical is a Chinese pharmaceutical manufacturer headquartered in the Benxi High-tech Industrial Development Zone, often referred to as the China Medicine Capital. The company specializes in the production of finished dosage forms, including tablets, capsules, and granules, covering both chemical pharmaceuticals and traditional Chinese medicines. Its product portfolio is diverse, with a strong presence in the markets for metabolic disease treatments, antibiotics, and over-the-counter cold and flu medications. Operating within a major industrial hub, the firm maintains multiple GMP-certified production lines to ensure high-volume output for the domestic market. The company is recognized for its focus on essential medicine accessibility and its contribution to the regional pharmaceutical supply chain.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Liaoning Xinshanyuan Pharmaceutical.